1. |
柳涛,蔡柏蔷.慢性阻塞性肺疾病诊断、处理和预防全球策略(2011 年修订版) 介绍.中国呼吸与危重监护杂志,2012,11:1-12.
|
2. |
Shaykhiev R,Crystal RG.Innate Immunity and Chronic Obstructive Pulmonary Disease.Gerontology,2013,59:481-489.
|
3. |
Gao J,Prasad N.Chronic obstructive pulmonary disease in China: the potential role of indacaterol.J Thorac Dis,2013,5:549-558.
|
4. |
陆再英,钟南山,主编.内科学.7版,北京:人民卫生出版社,2010:62.
|
5. |
Yang C,Mwaikambo BR,Zhu T,et al.Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways.Am J Physiol Regul Integr Comp Physiol,2008,294:R467-476.
|
6. |
Gyorgy B,Szabo TG,Pasztoi M,et al.Membranevesicles,currentstate-of-the-art: emergingrole of extracellularvesicles.Cell Mol Life Sci, 2011,68:2667-2688.
|
7. |
Jaiswal R,Luk F,Gong J,et al.Microparticleconferredmicro RNA profiles--implications in the transfer and dominance of cancertraits.Mol Cancer,2012,11:37.
|
8. |
焦燕,邱倩,杨再兴,等.淋巴细胞微粒刺激AKT/Foxo1阻滞气道上皮细胞周期的研究.第三军医大学学报,2012,24:2498-2502.
|
9. |
QIU Q, Xiong W,Yang C,et al.Lymphocyte-derived Microparticles induce bronchial epithelial cells'pro-inflammatory cytokine production and apoptosis.Mol Immunol,2013,55:220-230.
|
10. |
Rovina N,Koutsoukou A,Koulouris NG.Inflammation and Immune Response in COPD: Where Do We Stand? Mediators Inflamm,2013,2013:413735.
|
11. |
Brusselle GG,Joos GF,Bracke KR.New insights into the immunology of chronic obstructive pulmonary disease.Lancet,2011,378:1015-1026.
|
12. |
Guervilly C,Lacroix R,Forel JM,et al.Highlevels of circulatingleukocytemicroparticles are associated with betteroutcome in acuterespiratorydistresssyndrome.Crit Care,2011,15:R31.
|
13. |
Takahashi T,Kobayashi S,Fujino N,et al.Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.Thorax,2012,67:1067-1074.
|
14. |
Smyth LJ,Starkey C,Vestbo J,et al.CD4-Regulatory Cells in COPD Patients.Chest,2007,132:156-163.
|
15. |
Morel O,Toti F,Hugel B,et al.Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler.Arterioscler Thromb Vasc Biol,2006,26:2594-2604.
|
16. |
焦宪法, 王国斌,秦建领,等.支气管肺泡灌洗液中端粒酶检测临床价值研究.中国肺癌杂志,2002,5:275-277.
|
17. |
Jiang YY,Xiao W,Zhu MX,et al.The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease.Respir Med,2012,106:1680-1689.
|
18. |
He H,Ding L,Sun B,et al.Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.Crit Care,2012,16:R138.
|
19. |
Delabranche X,Berger A,Boisrame-Helms J,et al.Microparticles and infectious diseases.Med Mal Infect,2012,42:335-343.
|
20. |
Jy W,Horstman LL,Ahn YS.Microparticlesize and its relation to composition,functionalactivity,and clinicalsignificance.Semin Thromb Hemost,2010,36:876-880.
|
21. |
Diehl P,Aleker M,Helbing T,et al.Increased platelet,leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension.J Thromb Thrombolysis,2011,31:173-179.
|
22. |
Xue J,Kass DJ,Bon J,et al.Plasma B lymphocyte stimulator and B cell differentiationin idiopathic pulmonary fibrosis patients.J Immunol,2013,191:2089-2095.
|
23. |
Vander Strate BW,Postma DS,Brandsma CA,et al.Cigarette smoke-induced emphysema: A role for the B cell?Am J Respir Crit Care Med,2006,173:751-758.
|
24. |
Litsiou E,Semitekolou M,Galani IE,et al.CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2013,187:1194-1202.
|
25. |
Baka Z,Senolt L,Vencovsky J,et al.Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis.Immunol Lett,2010,128:124-130.
|
26. |
Miguet L,Bechade G,Fornecker L,et al.Proteomic analysis of malignant B-cellderivedmicroparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.J Proteome Res,2009,8:3346-3354.
|
27. |
Guiducci S,Ricci L,Romano E,et al.Microparticles and Kawasaki disease: a marker of vascular damage? Clin Exp Rheumatol,2011,29:S121-S125.
|
28. |
王娜,张湘燕,张程,等.慢性阻塞性肺疾病患者免疫功能的变化.贵州医药,2011,35:593-595.
|
29. |
McGorum BC,Dixon PM,Halliwell RE.Phenotypic analysis of peripheral blood and bronchoalveolar lavage fluid lymphocytes in control and chronic obstructivepulmonary disease affected horses,before and after natural (hay and straw) challenges.Vet Immunol Immunopathol,1993,36:207-222.
|
30. |
李冠华,李广生,赵芳,等.慢性阻塞性肺疾病急性加重期支气管肺泡灌洗液的细胞分类特点分析.国际呼吸杂志,2012,16:32.
|
31. |
Jy W, .Hor stamn LL, Ahn YS.Microparticle size and its relationto composition,functional activity,and clinical significance.Semin Thromb Hemost, 2010,36:876-880.
|
32. |
Tantawy AA,Adly AA,Ismail EA,et al.Flow cytometric assessment of circulating platelet anderythrocytes microparticles in young thalassemia majorpatients: relation to pulmonary hypertension and aorticwall stiffness.Eur J Haematol, 2013,90:508-518.
|